Smith Earl C MD is categorized under Hospital, Ama Approved Residency in Chicago, IL and active since 1918.
Smith Earl C MD was established in 1918, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hospital, Ama Approved Residency business, which does work in the B2C market, and is classified as a Hospital, Ama Approved Residency, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Earl Smith at the company’s single location by writing to 2720 West 15th St, Chicago, Illinois IL 60608 or by phoning (773) 542-2000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Smith Earl C MD |
| Contact Person: | Earl Smith |
| Address: | 2720 West 15th St, Chicago, Illinois 60608 |
| Phone Number: | (773) 542-2000 |
| Website Address: | sinaichildrenshospital.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1918 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospital, Ama Approved Residency |
| SIC Code: | 8062 |
| NAICS Code: | 6211110 |
| Share This Business: |
Smith Earl C MD was started in 1918 to provide professional Hospital, Ama Approved Residency under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Earl Smith for inquiries that concern Smith Earl C MD by calling the company number (773) 542-2000, as your correspondence is most welcome. Additionally, the physical location of the single location of Smith Earl C MD can be found at the coordinates 41.86108,-87.69426 as well as the street address 2720 West 15th St in Chicago, Illinois 60608.
For its online presence, you may visit Smith Earl C MD’s website at sinaichildrenshospital.org and engage with its social media outlets through on Twitter and on Facebook.